Literature DB >> 17395778

Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes.

Dong-Ming Kuang1, Yan Wu, Nini Chen, Jiasen Cheng, Shi-Mei Zhuang, Limin Zheng.   

Abstract

Macrophages (Mvarphi) in most solid tumors exhibit a distinct immunosuppressive phenotype, but the mechanisms that allow tumor microenvironments to "educate" Mvarphi are incompletely understood. Here, we report that culture supernatants (TSNs) from several types of tumor cell lines can drive monocytes to become immunosuppressive Mvarphi. Kinetic experiments revealed that soon after exposure to these TSNs, monocytes began to provoke transient proinflammatory responses and then became refractory to subsequent stimulation. Other TSNs that failed to cause such temporary preactivation did not alter Mvarphi polarization. Consistent with these results, we observed that the monocytes/Mvarphi in different areas of human tumor samples exhibited distinct activation patterns. Moreover, we found that hyaluronan fragments constitute a common factor produced by various tumors to induce the formation of immunosuppressive Mvarphi, and also that upregulation of hyaluronan synthase-2 in tumor cells is correlated with the ability of the cells to cause Mvarphi dysfunction. These results indicate that soluble factors derived from tumor cells, including hyaluronan fragments, co-opt the normal development of Mvarphi to dynamically educate the recruited blood monocytes in different niches of a tumor. The malignant cells can thereby avoid initiation of potentially dangerous Mvarphi functions and create favorable conditions for tumor progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395778     DOI: 10.1182/blood-2007-01-068031

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  84 in total

1.  Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma.

Authors:  Zhenyu Xiao; Haniee Chung; Babak Banan; Pamela T Manning; Katherine C Ott; Shin Lin; Benjamin J Capoccia; Vijay Subramanian; Ronald R Hiebsch; Gundumi A Upadhya; Thalachallour Mohanakumar; William A Frazier; Yiing Lin; William C Chapman
Journal:  Cancer Lett       Date:  2015-02-23       Impact factor: 8.679

2.  Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes.

Authors:  Qian Zhu; Mu-Yan Cai; Chang-Long Chen; Hao Hu; Huan-Xin Lin; Min Li; De-Sheng Weng; Jing-Jing Zhao; Ling Guo; Jian-Chuan Xia
Journal:  Oncoimmunology       Date:  2017-04-27       Impact factor: 8.110

3.  GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation.

Authors:  Colleen S Curran; Michael D Evans; Paul J Bertics
Journal:  J Immunol       Date:  2011-06-24       Impact factor: 5.422

Review 4.  Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity.

Authors:  Caroline Jochems; Jeffrey Schlom
Journal:  Exp Biol Med (Maywood)       Date:  2011-04-12

Review 5.  Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB.

Authors:  Thorsten Hagemann; Subhra K Biswas; Toby Lawrence; Antonio Sica; Claire E Lewis
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

6.  Monocytes/Macrophages promote vascular CXCR4 expression via the ERK pathway in hepatocellular carcinoma.

Authors:  Ya-Ming Meng; Jing Liang; Chong Wu; Jing Xu; Dan-Ni Zeng; Xing-Juan Yu; Huiheng Ning; Li Xu; Limin Zheng
Journal:  Oncoimmunology       Date:  2017-12-13       Impact factor: 8.110

7.  Can combination of osteopontin and peritumor-infiltrating macrophages be a prognostic marker of early-stage hepatocellular carcinoma?

Authors:  Yoo Jin Lee; Byoung Kuk Jang
Journal:  Hepatobiliary Surg Nutr       Date:  2014-04       Impact factor: 7.293

8.  Extracellular HSP110 skews macrophage polarization in colorectal cancer.

Authors:  Kevin Berthenet; Christophe Boudesco; Ada Collura; Magali Svrcek; Sarah Richaud; Arlette Hammann; Sebastien Causse; Nadhir Yousfi; Kristell Wanherdrick; Laurence Duplomb; Alex Duval; Carmen Garrido; Gaetan Jego
Journal:  Oncoimmunology       Date:  2016-04-22       Impact factor: 8.110

9.  High and low molecular weight hyaluronic acid differentially influence macrophage activation.

Authors:  Jamie E Rayahin; Jason S Buhrman; Yu Zhang; Timothy J Koh; Richard A Gemeinhart
Journal:  ACS Biomater Sci Eng       Date:  2015-07-13

10.  Modulation of macrophage cytokine profiles during solid tumor progression: susceptibility to Candida albicans infection.

Authors:  Marcela R Camargo; James Venturini; Fátima R Vilani-Moreno; Maria Sueli P Arruda
Journal:  BMC Infect Dis       Date:  2009-06-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.